Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Jul 18;14(1):124–131.e1. doi: 10.1016/j.cgh.2015.07.019

Table 2.

Risk factor distribution in the HCC cohort by cirrhosis category (N=1395)*. Risk factor distribution is not mutually exclusive as many patients had more than 1 risk factor.

Risk factor
n (%)
Level 1 evidence of no cirrhosis
n= 43
Level 2 evidence of no cirrhosis
n= 151
Confirmed Cirrhosis n=1201 P value
NAFLD 6 (5.6) 31 (28.9) 70 (65.4) <0.01
HCV 18 (1.9) 67 (7.0) 867 (91.1) <0.01
HBV 2 (3.1) 3 (4.6) 60 (92.3) 0.25
Alcohol abuse 29 (2.6) 96 (8.5) 1008 (88.9) <0.01
Metabolic syndrome 14 (3.9) 54 (15.1) 289 (80.9) <0.01
Others** 2 (8.0) 3 (12.0) 20 (80.0) 0.45
Idiopathic*** 2 (5.9) 11 (32.4) 21 (61.8) <0.01

HCV-hepatitis C virus; HBV-hepatitis B virus; NAFLD-nonalcoholic fatty liver disease

*

Of 1500, 105 had insufficient information to classify in any cirrhosis category

**

Others – Hemochromatosis, autoimmune hepatitis, alpha-1 antitrypsin deficiency

***

None of the above